Site FI-13
Site FI-13
Jarvenpaa, Finland1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Active, not recruiting | Phase 2 | 2025-12-17 | NCT05569239 |